I ran kratom in my own stack for 6 weeks last year. Low-dose leaf powder, 2 grams, mornings only, tracking HRV, sleep latency, and subjective pain scores after a shoulder injury that had me reaching for ibuprofen 4 times a day. My HRV held steady at 64. Sleep latency dropped from 22 minutes to 14. Pain scores went from a consistent 6 to a 3. Then I stopped, tracked the washout for 2 weeks, and saw no withdrawal symptoms, no rebound pain beyond baseline, no disruption to sleep architecture. N=1. I know. But here is what bothers me: nobody with actual funding is running the n=10,000 version of this experiment, and scheduling kratom federally would guarantee nobody ever does.
That is my position. Federal scheduling is premature, counterproductive, and driven by panic over synthetic derivatives rather than evidence against the plant itself.
The 7-OH Problem Is Real. The Response Is Wrong.
Synthetic 7-hydroxymitragynine is not kratom. It binds opioid receptors with far greater potency than the mitragynine in natural leaf. The FDA recommended scheduling it in July 2025. Fine. I have no objection to restricting a lab-synthesized compound that behaves more like fentanyl's cousin than a plant alkaloid. Ohio's emergency ban on synthetic kratom, Connecticut's Schedule I classification, the FDA's warning letters to 7 companies for adulterated products: these all target the same thing. Concentrated, synthetic, poorly labeled junk.
But watch the sleight of hand. Connecticut scheduled kratom itself alongside 7-OH. Nassau County banned all kratom sales outright. Kentucky's House Bill 757 proposes a statewide ban. The regulatory response keeps expanding from the synthetic derivative to the whole plant, and nobody is pausing to ask whether that expansion is justified by data.
It is not.
The 91 kratom-associated deaths the CDC identified over 18 months? Most involved polysubstance use. That is a confounding variable so large it swallows the conclusion. Meanwhile, ibuprofen, which I was taking daily before my kratom experiment, causes an estimated 16,500 deaths per year in the US from GI complications. Nobody is scheduling Advil.
Rhode Island Built the Protocol the Feds Won't
On April 3, Rhode Island became the first state to reverse its kratom ban. The new framework requires licensed sales, age verification at 21+, purity testing, and retailer training. It bans synthetic 7-OH. This is exactly the kind of systems-level approach I would design if someone handed me the problem: separate the dangerous derivative from the natural product, impose quality controls, and let adults make informed decisions.
I will grant the fair point: without federal standards, product quality varies wildly between states, and consumers in unregulated markets genuinely face contamination risks. That is a real problem. But the solution to contamination is testing and labeling, not prohibition. We do not ban supplements because some brands cut corners. We regulate manufacturing.
The Kratom Consumer Protection Act model, which several states have adopted, requires third-party lab testing, accurate labeling of alkaloid content, and age restrictions. It treats kratom like what it is: a pharmacologically active plant product that adults should be able to buy in a verified, standardized form.
Scheduling kills that entire framework. Schedule I means high abuse potential, no accepted medical use, no accepted safety profile. It means researchers need DEA licenses to study it. It means the chronic pain patient in Warwick, Rhode Island, who just got legal access 5 days ago loses it again. It means we never get the randomized controlled trials that everyone, including me, agrees we need.
Rep. Michelle McGaw said she is uncomfortable with a drug that works on opioid receptors without clean scientific trials. I respect that discomfort. But scheduling is the single most effective way to ensure those trials never happen. Cannabis sat in Schedule I for decades while researchers begged for permission to study it. We cannot afford to repeat that mistake with a plant that millions of Americans already use for pain and withdrawal management.
My shoulder is fine now. I stopped the kratom, started rehab, moved on. The compound was one tool in a temporary protocol. That is how most people use it. Let Rhode Island's experiment run. Fund the research. Stop confusing a synthetic crisis with a plant-based one.
